Article Text

Societal preferences for standard health insurance coverage in the Netherlands: a cross-sectional study
  1. Ineke van der Wulp1,
  2. Wilbert B van den Hout1,
  3. Marieke de Vries1,2,
  4. Anne M Stiggelbout1,
  5. Elske M van den Akker-van Marle1
  1. 1Department of Medical Decision Making, University Medical Center Leiden, Leiden, the Netherlands
  2. 2Department of Social Psychology, Tilburg University, Tilburg, the Netherlands
  1. Correspondence to Ineke van der Wulp; i.vanderwulp{at}hotmail.com

Abstract

Introduction Cost-effectiveness is an important criterion in the decision to cover interventions in health insurance packages. One of the outcome measures, the quality-adjusted life year, has been criticised on its assumptions and implications concerning life expectancy and quality of life. Several studies have been conducted that measured societal preferences concerning healthcare rationing decisions. These studies mainly focused on one attribute. To adjust quality-adjusted life year maximisation in accordance with societal preferences, the relative importance of attributes should be studied. The present study aims to measure the relative importance of age, gender, socioeconomic status, pre-intervention health state, treatment effect, chance of treatment success and number of people in need of the intervention. A secondary objective is to compare the validity of the willingness to pay method with the validity of a relatively new preference elicitation method, best–worst scaling.

Methods and analysis A representative sample of 2000 Dutch citizens, over 18 years of age, are recruited to complete a web-based survey containing treatment scenarios. The scenarios present different levels of attributes. Respondents are asked to select one of the four scenarios that they prefer to be covered by the Dutch standard health insurance package and one that they prefer not to be covered. They are also asked to indicate how much they are willing to pay for each treatment scenario. At the end of the survey, respondents are asked to rate every attribute on a 1–10 scale. Two versions of the questionnaire are developed which differ on the framing, that is, treatments can be added to or removed from the insurance package. The data will be analysed by means of sequential conditional logit analysis (best–worst scaling) and analysis of variance (willingness to pay).

Ethics and dissemination The protocol is reviewed and approved by the medical ethical committee of the University Medical Center Leiden.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Footnotes

  • To cite: van der Wulp I, van den Hout WB, de Vries M, et al. Societal preferences for standard health insurance coverage in the Netherlands: a cross-sectional study. BMJ Open 2012;2:e0001021. doi:10.1136/bmjopen-2012-001021

  • Contributors IvdW: developed study protocol and wrote the paper. WBvdH: developed study protocol and critically reviewed early drafts of the paper. MdV: developed study protocol and critically reviewed early drafts of the paper. AMS: developed study protocol and critically reviewed early drafts of the paper. MEvdA: developed study protocol and critically reviewed early drafts of the paper.

  • Funding This work was supported by the Netherlands Organisation for Health Research and Development (ZonMw), grant number: 152002019. This publication was financially supported by: The Netherlands Organisation for Scientific Research (NWO).

  • Competing interests None.

  • Ethics approval Ethics approval was provided by the ethical committee of Leiden University Medical Center.

  • Provenance and peer review Not commissioned; internally peer reviewed.